Clinic
Cypress Pediatrics, LLC
Cypress Pediatrics, LLC was paid $1.50M by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoCYPRESS PEDIATRICS, LLC
KENNER, LA 70065
KENNER, LA 70065
33aNPI1265772081assigned 02/15/2013
33bProvider typePrimary Care Clinic/Center
28Total paid$1.50M
24GClaims108,731
24DCodes billed72
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Louisiana
Rank by total paid#15 of 92
Median peer was paid$157K
This provider vs. median9.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,537 | $209K | |
| 2019 | 14,138 | $225K | |
| 2020 | 16,456 | $182K | |
| 2021 | 12,874 | $191K | |
| 2022 | 11,717 | $199K | |
| 2023 | 22,582 | $265K | |
| 2024incomplete | 20,427 | $226K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 8,054 | 5,982 | $446K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 13% | 3,791 | 2,965 | $201K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 3,533 | 2,712 | $162K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 4,713 | 3,508 | $158K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 6.2% | 8,900 | 6,450 | $93K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.2% | 1,601 | 1,171 | $77K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.2% | 697 | 539 | $62K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.3% | 5,768 | 3,771 | $49K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.0% | 469 | 317 | $30K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 2,842 | 2,150 | $28K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.8% | 8,204 | 5,348 | $27K |
| 97803 | 1.3% | 7,905 | 4,786 | $20K |
60 more codes
| 99188 | 1.3% | 2,143 | $20K | |
| 92551 | <1% | 2,048 | $12K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,325 | $11K |
| 90474 | <1% | 1,656 | $11K | |
| 99051 | <1% | 741 | $10K | |
| 85014 | <1% | 6,405 | $10K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 199 | $9K |
| 80061 | Lipid panel | <1% | 1,293 | $9K |
| 87428 | <1% | 193 | $9K | |
| 83655 | <1% | 1,105 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 182 | $5K |
| 87807 | <1% | 450 | $4K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 232 | $4K |
| 99173 | <1% | 3,526 | $4K | |
| 97802 | <1% | 734 | $3K | |
| 82947 | <1% | 1,304 | $3K | |
| 81002 | <1% | 2,065 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 37 | $2K |
| 99401 | <1% | 938 | $1K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12 | $937.32 |
| 36416 | <1% | 7,128 | $924.90 | |
| 90480 | <1% | 91 | $692.34 | |
| 96161 | <1% | 1,929 | $590.28 | |
| 90677 | <1% | 248 | $577.94 | |
| 84030 | <1% | 214 | $520.60 | |
| 96380 | <1% | 96 | $478.64 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 16 | $357.48 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 29 | $281.12 |
| 94760 | <1% | 526 | $198.93 | |
| 96127 | <1% | 516 | $154.50 | |
| 90473 | <1% | 199 | $135.59 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $94.10 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 77 | $63.08 |
| 96113 | <1% | 16 | $54.96 | |
| 90633 | <1% | 1,034 | $3.21 | |
| 90671 | <1% | 335 | $0.51 | |
| 90381 | <1% | 84 | $0.11 | |
| 90651 | <1% | 68 | $0.11 | |
| 99177 | <1% | 591 | $0.10 | |
| 91321 | <1% | 70 | $0.09 | |
| 90680 | 0% | 248 | $0.00 | |
| 90698 | 0% | 2,008 | $0.00 | |
| 90686 | 0% | 2,120 | $0.00 | |
| 90696 | 0% | 53 | $0.00 | |
| 90744 | 0% | 1,172 | $0.00 | |
| 3008F | 0% | 872 | $0.00 | |
| 90716 | 0% | 105 | $0.00 | |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | 0% | 16 | $0.00 |
| 90723 | 0% | 35 | $0.00 | |
| 90681 | 0% | 1,655 | $0.00 | |
| 90700 | 0% | 152 | $0.00 | |
| 90685 | 0% | 712 | $0.00 | |
| 90670 | 0% | 2,270 | $0.00 | |
| 90648 | 0% | 324 | $0.00 | |
| 90710 | 0% | 53 | $0.00 | |
| 90707 | 0% | 149 | $0.00 | |
| 90649 | 0% | 104 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 109 | $0.00 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 189 | $0.00 |
| 90713 | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFOTI, KAREN (OWNER)